Search results
Results from the WOW.Com Content Network
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
Methyl benzoate is an organic compound. It is an ester with the chemical formula C 6 H 5 COOCH 3, sometimes abbreviated as PhCO 2 Me, where Ph and Me are phenyl and methyl, respectively. Its structure is C 6 H 5 −C(=O)−O−CH 3. It is a colorless liquid that is poorly soluble in water, but miscible with organic solvents.
[3] Bromobenzene is used to introduce a phenyl group into other compounds. One method involves its conversion to the Grignard reagent, phenylmagnesium bromide. This reagent can be used, e.g. in the reaction with carbon dioxide to prepare benzoic acid. [4] Other methods involve palladium-catalyzed coupling reactions, such as the Suzuki reaction.
4-Bromobenzaldehyde, or p-bromobenzaldehyde, is an organobromine compound with the formula BrC 6 H 4 CHO. It is one of three isomers of bromobenzaldehyde . [ 3 ] It displays reactivity characteristic of benzaldehyde and an aryl bromide .
Profenofos can be synthesized by reacting phosphorus oxychloride with sodium ethoxide and sodium 1-propanethiolate, followed by treatment with 4-bromo-2-chlorophenol. [ 6 ] : 332 Toxicity
Ethyl ester of α-bromoisovaleric acid. According to the Farmak product label of Corvalol oral solution, the composition per 1 mL (26 drops) is as follows: [6] Ethyl ester of α-bromoisovaleric acid (ethyl 2-bromo-3-methylbutyrate) — 20 mg; Phenobarbital — 18.26 mg; Peppermint oil — 1.42 mg; Inactive ingredients: stabilizer, ethanol 96% ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.